How to Get Oral Micronized Progesterone in Oregon

Oregon Allows Telehealth and In-Person Progesterone Prescribing

Oregon state law authorizes licensed prescribers to write progesterone prescriptions through both traditional office visits and telehealth consultations. The Oregon Medical Board does not require a prior in-person visit before issuing a hormone therapy prescription via telemedicine, which means an initial video or audio consultation is sufficient for evaluation and prescribing.

Oral micronized progesterone received FDA approval for use alongside conjugated estrogens in postmenopausal women with an intact uterus [1]. The PEPI trial (N=875) established that micronized progesterone at 200 mg per day for 12 days per cycle provided endometrial protection comparable to medroxyprogesterone acetate (MPA) while producing a more favorable lipid profile [2]. That trial changed practice. It shifted many clinicians away from synthetic progestins and toward micronized progesterone, a pattern that holds in Oregon prescribing today.

To start the process, a patient schedules a consultation with a licensed Oregon prescriber or a telehealth provider registered in the state. The clinician reviews symptoms, medical history, and lab results before determining whether oral micronized progesterone is appropriate. Oregon does not impose state-level restrictions beyond standard DEA and medical board requirements for prescribing this medication.

Which Clinicians Can Prescribe in Oregon

MDs, DOs, nurse practitioners (NPs), and physician assistants (PAs) licensed in Oregon can all prescribe oral micronized progesterone. Oregon grants NPs full practice authority, meaning they do not need a collaborative agreement with a physician to prescribe hormone therapy [3].

This is a practical advantage. Rural Oregon counties with limited physician availability still have NP-staffed clinics and telehealth options. A patient in Harney County has the same prescribing access as someone in Portland, provided the clinician holds an active Oregon license.

Telehealth platforms that operate in Oregon must use providers credentialed in the state. Before choosing a platform, confirm the prescriber's Oregon license through the Oregon Medical Board or the Oregon State Board of Nursing verification portals.

Labs Required Before Starting Progesterone

Most prescribers order baseline labs before initiating oral micronized progesterone, though no Oregon-specific statute mandates a fixed lab panel. The Endocrine Society's 2015 clinical practice guideline for postmenopausal hormone therapy recommends the following baseline assessments before starting combined estrogen-progesterone therapy [4]:

• Serum estradiol (to confirm menopausal status or guide dosing)
• FSH (if menopausal status is uncertain)
• Progesterone level (baseline, if clinically indicated)
• Lipid panel (total cholesterol, LDL, HDL, triglycerides)
• Comprehensive metabolic panel (liver function, glucose, kidney markers)
• CBC (complete blood count)
• TSH (thyroid function)
• Mammogram (current within 12 months for women aged 40 and older)

Some telehealth providers ship at-home lab kits or partner with draw stations like Quest Diagnostics and Labcorp, both of which operate locations throughout Oregon. Turnaround for most panels runs 2 to 5 business days. Results are reviewed during the follow-up consultation, which may be the same visit where the prescription is written if labs were completed beforehand.

A 2020 North American Menopause Society (NAMS) position statement noted that "the decision to use hormone therapy should be individualized based on each woman's risk-benefit profile" [5]. That statement reinforced the importance of labs in quantifying cardiovascular and metabolic risk before treatment.

How Oregon Pharmacies Fill Progesterone Prescriptions

Oregon patients have two main pharmacy pathways: retail (commercial) pharmacies dispensing FDA-approved Prometrium or generic equivalents, and 503A compounding pharmacies that prepare custom formulations.

Retail pharmacies. Prometrium and its generics are stocked at major Oregon pharmacy chains including Walgreens, CVS, Rite Aid, Fred Meyer, and Costco. A 30-day supply of generic oral micronized progesterone 200 mg typically costs between $15 and $45 without insurance, depending on the pharmacy. GoodRx and similar discount platforms often bring cash prices below $20.

503A compounding pharmacies. Oregon licenses 503A compounding pharmacies through the Oregon Board of Pharmacy. These pharmacies can compound oral micronized progesterone in custom doses (for example, 50 mg or 150 mg capsules not available commercially) and ship within the state. Compounding is useful when a patient needs a peanut-oil-free formulation due to peanut allergy, since brand-name Prometrium contains peanut oil as an excipient [1].

Oregon's 503A pharmacies must comply with USP 795 and 797 standards for non-sterile and sterile compounding, respectively. Patients can verify a pharmacy's license status through the Oregon Board of Pharmacy's license lookup tool.

Oregon Medicaid Coverage and Prior Authorization

Oregon Health Plan (Medicaid) covers oral micronized progesterone for endometrial protection during estrogen-based HRT. Coverage requires prior authorization (PA).

The PA process involves the prescriber submitting documentation to the Oregon Health Authority (OHA) or the patient's coordinated care organization (CCO). Required documentation typically includes:

• A confirmed diagnosis (ICD-10 codes for menopause-related conditions, such as N95.1 for menopausal and female climacteric states)
• Evidence of concurrent estrogen therapy
• Confirmation that the patient has an intact uterus
• Clinical notes supporting medical necessity

Processing time for PA requests varies by CCO but generally takes 2 to 5 business days. Urgent PA requests can be processed within 24 hours. If denied, Oregon Medicaid beneficiaries can appeal through OHA's administrative hearings process.

For commercially insured patients, most Oregon health plans cover generic oral micronized progesterone on formulary tier 1 or tier 2. Brand-name Prometrium may require step therapy (trying a generic first) or PA depending on the plan. The AACE/ACE 2017 guidelines recommend micronized progesterone as a preferred progestin for HRT, which supports medical necessity arguments during appeals [6].

Dosing: Continuous vs. Cyclic Regimens

The FDA-approved labeling for Prometrium specifies two dosing schedules for endometrial protection [1]:

Continuous regimen. 100 mg orally at bedtime, taken every night without interruption alongside daily estrogen. This approach avoids scheduled withdrawal bleeding and is often preferred by patients further from their final menstrual period.

Cyclic regimen. 200 mg orally at bedtime for 12 consecutive days per 28-day cycle (typically calendar days 1 through 12 or days 15 through 26, depending on the prescriber's protocol). Cyclic dosing produces a predictable withdrawal bleed in most patients.

The PEPI trial demonstrated that both regimens protected the endometrium from hyperplasia during 36 months of follow-up [2]. A secondary analysis from PEPI showed that micronized progesterone 200 mg cyclically increased HDL cholesterol by 4.1 mg/dL compared to baseline, while MPA 2.5 mg continuously decreased HDL by 2.4 mg/dL [2]. That lipid advantage is one reason the Endocrine Society and NAMS guidelines favor micronized progesterone over synthetic alternatives.

Bedtime dosing is standard. Oral micronized progesterone produces a metabolite (allopregnanolone) with sedative properties, which can cause dizziness and drowsiness [1]. Taking the capsule at bedtime turns this side effect into a therapeutic benefit for patients with menopause-related sleep disturbance. A 2001 study published in Fertility and Sterility (N=27) found that oral micronized progesterone improved sleep efficiency by a mean of 7.4% compared to placebo in postmenopausal women [7].

Telehealth Platforms Serving Oregon Patients

Several HIPAA-compliant telehealth platforms prescribe oral micronized progesterone to Oregon residents. When evaluating a platform, verify these criteria:

1. Oregon-licensed prescribers. The platform must use clinicians with active Oregon medical, NP, or PA licenses.
2. Lab integration. The platform should order labs through Oregon-accessible draw stations or ship at-home kits.
3. Pharmacy partnerships. Confirm the platform sends prescriptions to Oregon-licensed retail or compounding pharmacies.
4. Follow-up cadence. NAMS recommends reassessment within 3 to 6 months of initiating HRT, then annually [5]. The platform should build this into its care model.

Telehealth visits for hormone therapy evaluation typically last 20 to 40 minutes. Many platforms offer asynchronous intake (filling out symptom questionnaires and uploading lab results before the visit), which shortens the synchronous consultation.

Oregon does not require telehealth providers to maintain a physical office in the state. Out-of-state telehealth companies can serve Oregon patients as long as their prescribers hold valid Oregon licenses.

Timeline: From Consultation to First Dose

The total time from initial consultation to receiving oral micronized progesterone in Oregon typically ranges from 3 to 10 business days. Here is a breakdown by step:

• Scheduling and intake: 0 to 2 days (some platforms offer same-day consultations)
• Lab draw and results: 2 to 5 days (if labs were not completed prior to scheduling)
• Clinical review and prescribing: 0 to 1 day after lab results are available
• Pharmacy fill and delivery: 1 to 3 days for retail pickup; 2 to 5 days for mail-order or compounding pharmacy shipping

Patients who arrive at their consultation with recent lab results (within 6 months and meeting the prescriber's requirements) can receive a prescription the same day. Retail pharmacies in metro areas like Portland, Eugene, Salem, and Bend often fill progesterone prescriptions within hours.

Transferring a Progesterone Prescription to Oregon

Patients relocating to Oregon or traveling within the state can transfer an existing oral micronized progesterone prescription from another state. Oregon Board of Pharmacy regulations permit prescription transfers between licensed pharmacies, including interstate transfers.

The process requires the patient to contact their new Oregon pharmacy and provide the name and phone number of the originating pharmacy. The receiving pharmacist contacts the transferring pharmacist directly to verify and accept the prescription. Controlled substance transfer rules do not apply here, as progesterone is not a scheduled drug under federal or Oregon law.

For patients using telehealth, the simpler approach is often to schedule a new consultation with an Oregon-licensed provider, especially if the original prescriber is not licensed in Oregon. This also resets the follow-up cycle and ensures continuity of care under a provider who can order Oregon-accessible labs.

Safety Considerations and Contraindications

Oral micronized progesterone carries FDA black-box warnings consistent with all progestational agents used in combination with estrogen [1]. Contraindications include:

• Known or suspected breast cancer
• Active deep vein thrombosis, pulmonary embolism, or history of these conditions
• Active arterial thromboembolic disease (stroke, myocardial infarction)
• Known hepatic dysfunction or disease
• Known allergy to progesterone, peanuts (for Prometrium specifically), or any capsule excipient
• Undiagnosed abnormal uterine bleeding

The Women's Health Initiative (WHI) Memory Study found that combined estrogen-progestin therapy increased the risk of probable dementia in women aged 65 and older (HR 2.05 to 95% CI 1.21 to 3.48) [8]. However, the WHI used medroxyprogesterone acetate, not micronized progesterone. The French E3N cohort study (N=80,377) found that estrogen combined with micronized progesterone did not significantly increase breast cancer risk (RR 1.00 to 95% CI 0.83 to 1.22) over a mean follow-up of 8.1 years, while estrogen combined with synthetic progestins did (RR 1.69 to 95% CI 1.50 to 1.91) [9].

Dr. JoAnn Manson, principal investigator of the WHI and professor at Harvard Medical School, has stated: "The type of progestogen matters. Micronized progesterone and some newer progestins appear to have a better safety profile than medroxyprogesterone acetate" [10].

Compounding vs. Brand-Name Prometrium: What Oregon Patients Should Know

The choice between brand Prometrium, generic micronized progesterone, and compounded progesterone depends on clinical need, allergy status, and cost.

Generic micronized progesterone is bioequivalent to Prometrium and is the most cost-effective option. It still contains peanut oil. Patients with documented peanut allergy need a compounded formulation using an alternative oil base (olive oil or sesame oil are common substitutes).

Compounded progesterone in Oregon must be prescribed by a licensed clinician and filled at a 503A-licensed pharmacy. The FDA does not verify compounded drug bioequivalence, so the American College of Obstetricians and Gynecologists (ACOG) recommends FDA-approved products when available and clinically appropriate [11]. ACOG's Committee Opinion No. 532 states: "The use of compounded bioidentical hormone preparations should be limited to situations in which an FDA-approved alternative is not available or tolerated."

Compounded formulations may also be appropriate for patients who need non-standard doses. For example, some clinicians prescribe 50 mg or 150 mg for dose titration during the initiation phase, and these strengths are not commercially manufactured.